Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Ocuspecto Oy
OY
Active
Y-tunnus 2478157-7
Kaarinantie 700, 20540
Turku
Research and development on medical sciences
·
NACE 72191
Est. 2012 · 14 years old
— employees
Share
Finland
/
Companies
/
Research and development on medical sciences
/
Ocuspecto Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
0M
-1M
-1M
2018: 0M
0M
2018
2019: 0M
0M
2019
2020: 0M
0M
2020
EBITDA
EUR millions
0M
0M
-1M
-1M
-1M
2018: -1M
-1M
2018
2019: -1M (0% vs 2018)
-1M
0%
2019
2020: 0M (+100% vs 2019)
0M
2020
Income statement
EUR thousands
Item
2020
2019
2018
Revenue
214
171
169
Staff expenses
−365
−736
−945
EBITDA
−315
−660
−970
Depreciation & amort.
−202
−201
−187
EBIT
−517
−861
−1 157
Net financials
−40
−34
−46
Profit before tax
−557
−895
−1 203
Tax
−0
−0
−0
Net profit
−557
−895
−1 203
Balance sheet
EUR thousands
Item
2020
2019
2018
Total assets
2 096
2 131
2 292
Equity
−372
−86
100
Long-term debt
1 987
1 771
1 610
Short-term debt
482
446
582
Total debt
2 468
2 217
2 192
Financial ratios
5-year trend
EBITDA margin
−147,2 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2018
2020
Equity ratio
−17,7 %
This company
38,2 %
Market median
This company
Market median
146% below market
2018
2020
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2018
2020
Net profit margin
−260,8 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2018
2020
Asset turnover
0,10×
This company
1,12×
Market median
This company
Market median
91% below market
2018
2020
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2018
2020
Annual reports & filings
Annual report 2020
Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via PRH / YTJ · Period 2018-01-01 – 2018-12-31
View
PDF
More on Ocuspecto Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
